BioNTech SE

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE engages in the development of novel medicines at the intersection of immunology and synthetic biology. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.

CEO

Ugur Sahin

CEOUgur Sahin

Employees

3,082

Employees3,082

Headquarters

Mainz, Rheinland-Pfalz

HeadquartersMainz, Rheinland-Pfalz

Founded

2008

Founded2008

Employees

3,082

Employees3,082

BNTX Key Statistics

Market cap

32.52B

Market cap32.52B

Price-Earnings ratio

2.37

Price-Earnings ratio2.37

Dividend yield

—

Dividend yield—

Average volume

1.00M

Average volume1.00M

High today

$135.62

High today$135.62

Low today

$129.01

Low today$129.01

Open price

$129.45

Open price$129.45

Volume

932.62K

Volume932.62K

52 Week high

$374.58

52 Week high$374.58

52 Week low

$117.08

52 Week low$117.08

Analyst ratings

56%

of 16 ratings

Buy

43.8%

Hold

56.3%

Sell

BNTX Earnings

-$0.18

$5.20

$10.59

$15.97

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 8, Pre-Market

ActualExpected Nov 8, Pre-Market